Literature DB >> 14762276

Duck hepatitis B virus model in the study of hepatitis B virus.

Lucyna Cova1, Fabien Zoulim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14762276     DOI： 10.1385/1-59259-670-3:261

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  12 in total

1.  Activity of nucleic acid polymers in rodent models of HBV infection.

Authors:  Katrin Schöneweis; Neil Motter; Pia L Roppert; Mengji Lu; Baoju Wang; Ingo Roehl; Dieter Glebe; Dongliang Yang; John D Morrey; Michael Roggendorf; Andrew Vaillant
Journal:  Antiviral Res       Date:  2017-11-08       Impact factor: 5.970

Review 2.  Modeling hepatitis B virus infection, immunopathology and therapy in mice.

Authors:  Liang Cheng; Feng Li; Moses T Bility; Christopher M Murphy; Lishan Su
Journal:  Antiviral Res       Date:  2015-06-19       Impact factor: 5.970

3.  IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.

Authors:  Jian-Er Long; Li-Na Huang; Zhi-Qiang Qin; Wen-Yi Wang; Di Qu
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

4.  Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.

Authors:  Mohammad-Khalid Parvez; Deepak Sehgal; Shiv-Kumar Sarin; Seemi-Farhat Basir; Shahid Jameel
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

5.  Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.

Authors:  Kai Dallmeier; Ursula Schultz; Michael Nassal
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

6.  Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.

Authors:  Ingo Roehl; Stephan Seiffert; Celia Brikh; Jonathan Quinet; Catherine Jamard; Nadine Dorfler; Jennifer A Lockridge; Lucyna Cova; Andrew Vaillant
Journal:  Mol Ther Nucleic Acids       Date:  2017-05-04       Impact factor: 8.886

7.  Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide.

Authors:  Fabien Abdul; Bénédicte Ndeboko; Thierry Buronfosse; Fabien Zoulim; Michael Kann; Peter E Nielsen; Lucyna Cova
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 8.  Therapeutic Potential of Cell Penetrating Peptides (CPPs) and Cationic Polymers for Chronic Hepatitis B.

Authors:  Bénédicte Ndeboko; Guy Joseph Lemamy; Peter E Nielsen; Lucyna Cova
Journal:  Int J Mol Sci       Date:  2015-11-27       Impact factor: 5.923

9.  Transcriptome analysis of duck liver and identification of differentially expressed transcripts in response to duck hepatitis A virus genotype C infection.

Authors:  Cheng Tang; Daoliang Lan; Huanrong Zhang; Jing Ma; Hua Yue
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication.

Authors:  Bénédicte Ndeboko; Narayan Ramamurthy; Guy Joseph Lemamy; Catherine Jamard; Peter E Nielsen; Lucyna Cova
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.